Wird geladen...
Safety of axitinib and sorafenib monotherapy for patients with renal cell carcinoma: a meta-analysis
We sought to investigate safety of axitinib or sorafenib in renal cell carcinoma (RCC) patients and compare toxicity of these two vascular endothelial growth factor receptor inhibitors. Databases of PubMed and Embase were searched. We included phase II and III prospective trials, as well as retrospe...
Gespeichert in:
| Veröffentlicht in: | J Biomed Res |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Editorial Department of Journal of Biomedical Research
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956256/ https://ncbi.nlm.nih.gov/pubmed/29353818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.32.20170080 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|